198 related articles for article (PubMed ID: 25880440)
21. Current Lynch syndrome tumor screening practices: a survey of genetic counselors.
Cohen SA
J Genet Couns; 2014 Feb; 23(1):38-47. PubMed ID: 23674164
[TBL] [Abstract][Full Text] [Related]
22. Universal Screening for Lynch Syndrome Compared with Pedigree-Based Screening: 10-Year Experience in a Tertiary Hospital.
Kim MH; Kim DW; Lee HS; Bang SK; Seo SH; Park KU; Oh HK; Kang SB
Cancer Res Treat; 2023 Jan; 55(1):179-188. PubMed ID: 35313100
[TBL] [Abstract][Full Text] [Related]
23. Barriers and facilitators affecting the implementation of substance use screening in primary care clinics: a qualitative study of patients, providers, and staff.
McNeely J; Kumar PC; Rieckmann T; Sedlander E; Farkas S; Chollak C; Kannry JL; Vega A; Waite EA; Peccoralo LA; Rosenthal RN; McCarty D; Rotrosen J
Addict Sci Clin Pract; 2018 Apr; 13(1):8. PubMed ID: 29628018
[TBL] [Abstract][Full Text] [Related]
24. Underutilization of Lynch Syndrome Screening at Two Large Veterans Affairs Medical Centers.
Mittal C; Dang D; Stoffel E; Menees S; Scott FI; Ahnen D; Patel SG
Dig Dis Sci; 2020 Nov; 65(11):3305-3315. PubMed ID: 32500284
[TBL] [Abstract][Full Text] [Related]
25. Implementation of Universal Tumor Screening of Colorectal Cancer for Detection of Lynch Syndrome at a Hispanic-Rich County Hospital.
Snedden TW; McCracken A; Vaidyanathan A; Taranova A; Villarreal R; Qamar S; Arora SP
JCO Oncol Pract; 2020 Sep; 16(9):e948-e957. PubMed ID: 32452745
[TBL] [Abstract][Full Text] [Related]
26. Costs and outcomes of Lynch syndrome screening in the Australian colorectal cancer population.
Cenin DR; Naber SK; Lansdorp-Vogelaar I; Jenkins MA; Buchanan DD; Preen DB; Ee HC; O'Leary P
J Gastroenterol Hepatol; 2018 Oct; 33(10):1737-1744. PubMed ID: 29645364
[TBL] [Abstract][Full Text] [Related]
27. Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome.
Watkins JC; Yang EJ; Muto MG; Feltmate CM; Berkowitz RS; Horowitz NS; Syngal S; Yurgelun MB; Chittenden A; Hornick JL; Crum CP; Sholl LM; Howitt BE
Int J Gynecol Pathol; 2017 Mar; 36(2):115-127. PubMed ID: 27556954
[TBL] [Abstract][Full Text] [Related]
28. Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice.
Cohen SA; Laurino M; Bowen DJ; Upton MP; Pritchard C; Hisama F; Jarvik G; Fichera A; Sjoding B; Bennett RL; Naylor L; Jacobson A; Burke W; Grady WM
Cancer; 2016 Feb; 122(3):393-401. PubMed ID: 26480326
[TBL] [Abstract][Full Text] [Related]
29. Implementation of a Systematic Tumor Screening Program for Lynch Syndrome in an Integrated Health Care Setting.
Clarke EV; Muessig KR; Zepp J; Hunter JE; Syngal S; Acheson LS; Wiesner GL; Peterson SK; Bergen KM; Shuster E; Davis JV; Schneider JL; Kauffman TL; Gilmore MJ; Reiss JA; Rope AF; Cook JE; Goddard KAB
Fam Cancer; 2019 Jul; 18(3):317-325. PubMed ID: 30729418
[TBL] [Abstract][Full Text] [Related]
30. Health workers' perspectives on barriers and facilitators to implementing a new national cervical cancer screening program in Ethiopia.
Lott BE; Halkiyo A; Kassa DW; Kebede T; Dedefo A; Ehiri J; Madhivanan P; Carvajal S; Soliman A
BMC Womens Health; 2021 May; 21(1):185. PubMed ID: 33941159
[TBL] [Abstract][Full Text] [Related]
31. Impact of universal immunohistochemistry on Lynch syndrome diagnosis in an Australian colorectal cancer cohort.
Loh Z; Williams DS; Salmon L; Dow E; John T
Intern Med J; 2019 Oct; 49(10):1278-1284. PubMed ID: 30667141
[TBL] [Abstract][Full Text] [Related]
32. Evaluating the impact of universal Lynch syndrome screening in a publicly funded healthcare system.
Lee PWC; Bedard AC; Samimi S; Beard VK; Hong Q; Bedard JEJ; Gilks B; Schaeffer DF; Wolber R; Kwon JS; Lim HJ; Sun S; Schrader KA
Cancer Med; 2020 Sep; 9(18):6507-6514. PubMed ID: 32700475
[TBL] [Abstract][Full Text] [Related]
33. Implementing and using quality measures for children's health care: perspectives on the state of the practice.
Shaller D
Pediatrics; 2004 Jan; 113(1 Pt 2):217-27. PubMed ID: 14702504
[TBL] [Abstract][Full Text] [Related]
34. Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center.
Moline J; Mahdi H; Yang B; Biscotti C; Roma AA; Heald B; Rose PG; Michener C; Eng C
Gynecol Oncol; 2013 Jul; 130(1):121-6. PubMed ID: 23612316
[TBL] [Abstract][Full Text] [Related]
35. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.
Najdawi F; Crook A; Maidens J; McEvoy C; Fellowes A; Pickett J; Ho M; Nevell D; McIlroy K; Sheen A; Sioson L; Ahadi M; Turchini J; Clarkson A; Hogg R; Valmadre S; Gard G; Dooley SJ; Scott RJ; Fox SB; Field M; Gill AJ
Pathology; 2017 Aug; 49(5):457-464. PubMed ID: 28669579
[TBL] [Abstract][Full Text] [Related]
36. Impact of age cutoffs on a lynch syndrome screening program.
Gudgeon JM; Belnap TW; Williams JL; Williams MS
J Oncol Pract; 2013 Jul; 9(4):175-9. PubMed ID: 23942916
[TBL] [Abstract][Full Text] [Related]
37. Mismatch repair protein immunohistochemistry: a useful population screening strategy for Lynch syndrome.
Musulén E; Sanz C; Muñoz-Mármol AM; Ariza A
Hum Pathol; 2014 Jul; 45(7):1388-96. PubMed ID: 24768606
[TBL] [Abstract][Full Text] [Related]
38. Lynch syndrome screening implementation: business analysis by a healthcare system.
Gudgeon JM; Williams JL; Burt RW; Samowitz WS; Snow GL; Williams MS
Am J Manag Care; 2011 Aug; 17(8):e288-300. PubMed ID: 21851136
[TBL] [Abstract][Full Text] [Related]
39. First-year implementation of mailed FIT colorectal cancer screening programs in two Medicaid/Medicare health insurance plans: qualitative learnings from health plan quality improvement staff and leaders.
Baldwin LM; Schneider JL; Schwartz M; Rivelli JS; Green BB; Petrik AF; Coronado GD
BMC Health Serv Res; 2020 Feb; 20(1):132. PubMed ID: 32085767
[TBL] [Abstract][Full Text] [Related]
40. Patterns of germline and somatic testing after universal tumor screening for Lynch syndrome: A clinical practice survey of active members of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer.
Hodan R; Rodgers-Fouche L; Arora S; Dominguez-Valentin M; Kanth P; Katona BW; Mraz KA; Roberts ME; Vilar E; Soto-Azghani CM; Brand RE; Esplin ED; Perez K
J Genet Couns; 2022 Aug; 31(4):949-955. PubMed ID: 35218578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
